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The incidence of lower urinary tract dysfunctions (LUTDs) in women increases with 
age. These dysfunctions include incontinence, recurrent urinary bladder infection, and 
poor bladder and urethral contraction. There is a corresponding progressive decrease 
in mean circulating estrogen as women age. We have data indicating that the rate at 
which LUTDs develop and progress is directly related to the decrease in circulating 
estrogen. Our studies on rabbits indicate that low circulating estrogen mediates a de-
crease in blood flow to the bladder and urethra. This in turn results in mucosal and 
smooth muscle hypoxia and the generation and release of free radicals. The end re-
sult is slow progressive oxidation damage of cellular and subcellular membranes (pro-
tein, lipids, and phospholipids), which relates directly to the etiology of age-related 
progressive LUTD. Estrogen administration to ovariectomized rabbits reverses these 
effects while causing smooth muscle hypertrophy, mucosal hyperplasia, increased 
vascularity and blood flow, fully oxygenated tissue, and reduced oxidative damage.
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1. Introduction
1.1.  Lower urinary tract dysfunctions in women 
and aging
Incontinence, recurrent urinary tract infections, and poor 
detrusor contraction in women all increase as a function 
of age.1–8 In a study presented by The Bladder Health 
Council of the American Foundation for Urologic Disease, it 
was stated that incontinence affects more than 10 million 
Americans, 85% of whom are women. It affects 20% of 
women over the age of 45, and this number increases with 
age. Characterized by a high morbidity rate, incontinence 
is associated with a loss of self-esteem, an inability to 
work, and is a major stress factor. It can result in an ex-
tremely altered lifestyle and is the main reason that 
women are admitted to nursing homes. Care for the eld-
erly incontinent patient represents an enormous expense 
nationally.3,4 In addition to incontinence, bladder infec-
tion becomes increasingly prevalent in the aging female.5,6 
It is a major source of pain especially in relation to inter-
course and can become a major sexual problem for women 
after menopause. In addition to frequent lower urinary 
tract infections, atrophy of the vaginal mucosa and under-
lying musculature also results in pain during intercourse 
and significant sexual problems. Many if not all of these 
age-related dysfunctions can be linked to decreasing cir-
culating estrogen during and post menopause.1–8
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1.2.  Importance of α-adrenergic tension 
(urethra) for continence
Several investigators have estimated that 30–50% of the 
total urethral pressure is contributed by smooth muscle 
(SM) tone. The relative contribution of SM tension is 
greater in females than in males; vascular compression, 
abdominal pressure, and connective tissue and elastic 
components of the urethra also contribute to urethral 
closure pressure.9,10 It is clear from animal and human 
data that during bladder filling, there is a progressive in-
crease in the sympathetic stimulation of the urethra which 
causes increased α-adrenergic tension.11,12 In men and 
women, α-adrenergic stimulation has proven to be ef-
fective for treating specific forms of incontinence. Diokno 
and Taub13 reported that ephedrine sulfate treatment was 
effective for treating sphincter incontinence in 27 out of 
38 patients. Awad et al.14 showed that norepinephrine 
administration caused a significant increase in both max-
imal urethral pressure and maximal urethral closure pres-
sure. Several objective clinical studies have shown that 
the α-agonist phenylpropanolamine is an effective ther-
apeutic agent for stress and sphincter incontinence.15,16 
Thus, there is a solid base of clinical information showing 
that α-adrenergic stimulation (especially using chronic 
slow-release therapy) increases maximal urethral pressure 
and maximal urethral closure pressure, and significantly 
reduces stress and sphincter incontinence. Alternately, 
there is considerable evidence that antihypertensive ther-
apy with α-adrenergic antagonists such as prazosin can 
induce moderate to severe stress incontinence.13–18 In 
normal healthy women, prazosin administration caused 
a significant reduction in urethral closure pressure.19
These studies provide clinical evidence that tonic 
α-adrenergic stimulation is a major factor in the main-
tenance of continence in women. Similarly, reduced 
urethral pressure was observed in rats treated with alfu-
zosin.20 Thus, there is a close correlation between clinical 
studies in women and basic studies in animals regarding 
the importance of α-adrenergic function in the mainte-
nance of urethral tension and continence during bladder 
filling.
In association with aging, there is a progressive reduc-
tion in the contractile responses to both bladder detrusor 
SM in response to muscarinic stimulation and decreased 
urethral contraction in response to α-adrenergic stimu-
lation. The result is an increased incidence of incontinence 
because of the lower urethral pressure during filling and 
poor emptying during micturition. Again, these changes 
correspond with decreased levels of circulating estrogen 
associated with aging.
1.3.  Effect of hormonal manipulation on lower 
urinary tract structure and function
Periods of marked changes in female hormone levels, such 
as puberty, pregnancy and menopause, induce significant 
alterations in the lower urinary tract.21–23 Although there 
is considerable contradictory data published on the spe-
cific effects of ovariectomy, pregnancy and estrogen ad-
ministration on lower urinary tract innervation, receptor 
density and distribution, and contractile function, it is 
clear that ovariectomy, pregnancy and hormone admin-
istration induce pronounced alterations in the lower uri-
nary tract. The conflicting data reflect the widely varying 
methodologies (duration of ovariectomy, dose, and route 
of hormone administration, etc.) and species utilized.24
Hodgson and co-workers25 found a decreased sensi-
tivity of urethral strips to phenylephrine 14 days after 
ovariectomy when compared with urethral strips from 
controls. Estradiol treatment prevented the change in sen-
sitivity. Larsson and co-workers26, using a perfused ure-
thra preparation, reported that treating mature female 
rabbits with polyestradiol increased the sensitivity of 
the urethra to norepinephrine. Another study examined 
the contractile responses to different α-adrenergic ago-
nists of the proximal urethras from male and female rab-
bits.27 The magnitude of the increase in urethral pressure 
in response to α2-agonists was twofold greater in ure-
thras from males than from females; the response to α1-
agonists, however, was greater in urethras from females 
than from males. While α1-agonists caused a rapid con-
traction, the response to α2-agonists was gradual.
1.4. Neurotransmitter receptors
There have been many studies examining changes in au-
tonomic receptor densities in the lower urinary tract 
after ovariectomy and/or estrogen treatment. Polyestra-
diol treatment of mature female rabbits caused increased 
α-adrenergic receptor density in the rabbit urethra.26 
Levin et al.28,29 found that treating immature female rab-
bits with estradiol caused an increased bladder-body re-
sponse to α-adrenergic stimulation that corresponded 
to an increase in α-adrenergic receptor density. Shapiro30 
found that low-dose estradiol treatment after ovariec-
tomy caused no change in bladder muscarinic receptor 
density. Batra and Andersson31 reported a decrease in 
muscarinic-receptor density following ovariectomy, which 
was not reversed by estradiol treatment.
1.5. Lipids and lipid mediators
One area of study which has been overlooked in the field 
of LUTD is the role of lipids and lipid mediators as etio-
logic factors in the etiology of these dysfunctions.32–43 
The following is a brief review of the mediators which 
may play a major role.
Eicosanoids are signaling molecules made by oxy-
genation of 20-carbon essential fatty acids. They exert 
complex control over many bodily systems and are mainly 
involved in mediating/reducing inflammation. The net-
works of controls that depend upon eicosanoids are 
among the most complex in the human body. Eicosanoids 
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derive from either omega-3 (ω-3) or omega-6 (ω-6) es-
sential fatty acids. The ω-6 eicosanoids are generally 
proinflammatory while ω-3’s are much less so. Anti-
inflammatory drugs such as aspirin and other NSAIDs act 
by downregulating eicosanoid synthesis. There are four 
families of eicosanoids: prostaglandins, prostacyclins, 
thromboxanes, and leukotrienes.
Prostaglandins are lipid compounds that are derived 
enzymatically from fatty acids and have important modula-
tory functions in the body. Every prostaglandin contains 
20 carbon atoms, including a five-carbon ring. The prostag-
landins, together with the thromboxanes and prostacyclins, 
form the prostanoid class of fatty acid derivatives. The 
prostanoid is a subclass of eicosanoids. Leukotrienes are 
fatty molecules of the immune system that contribute to 
inflammation. Leukotrienes are naturally produced eicosa-
noid lipid mediators. Leukotrienes use both autocrine 
signaling and paracrine signaling to regulate the body’s 
response. Leukotrienes are produced in the body from ara-
chidonic acid by the enzyme 5-lipoxygenase. Their produc-
tion usually accompanies the production of histamine and 
may be involved in conditions like interstitial cystitis.
A phospholipase is an enzyme that hydrolyzes phos-
pholipids into fatty acids and other lipophilic substances. 
There are four major classes, which are termed A, B, C 
and D (with various subtypes) and distinguished by what 
type of reaction they catalyze. In the bladder, phospholi-
pase C has been linked to muscarinic receptor activity. 
Phospholipase A has been shown to have a role in mu-
cosal function.32–43
In addition, there is excellent evidence in the literature 
that lipid mediators are directly involved in age-related 
dysfunctions including Alzheimer disease, cardiovascu-
lar disease, osteoporosis, and others.44–49 As mentioned 
previously, estrogen is an important endogenous com-
pound for maintaining lower urinary tract function in 
women and female laboratory animals.3,23,24,50 Estrogen 
is also known to modulate the sensitivity of the rat blad-
der to prostaglandins, presumably through the regulation 
of specific receptors.51 It has also been reported that es-
trogen stimulates prostaglandin synthesis by regulating 
the activities of specific lipases and phospholipases, re-
sulting in modulations of phospholipase A2 and cyclo-
oxygenase activity through genomic and non-genomic 
mechanisms.52–55 Prostaglandins E2, I2 and F2α, and throm-
boxane A2 have been found in the bladder mucosa of 
humans, rabbits, and rats.56,57 Thus, there is a close asso-
ciation between lipid and phospholipid metabolism and 
estrogen modulation of bladder function.
In addition, all cellular and subcellular membranes 
and structures have lipid/phospholipid membrane struc-
tures that are integral to the function and well being of 
the cell or structure. Any change in the phospholipid 
(PPL) or free fatty acid (FFA) content can significantly af-
fect membrane fluidity, permeability and receptor func-
tion, and thus significantly affect cellular function. Our 
preliminary studies have clearly demonstrated that 
ovariectomy significantly affects the FFA and PPL content 
and metabolism. In addition, several bioactive prostag-
landin levels have significantly changed, which would 
have significant physiologic effects.
As mentioned previously, detrusor and urethral SM 
dysfunction associated with aging are major health 
problems.1–4 We hypothesize that both detrusor and 
urethral SM weakness (decreased detrusor contraction 
during micturition and decreased urethral tone during 
bladder filling) in relation to aging results in part from a 
generalized decrease in the metabolic energy available 
to sustain SM tension because of the postmenopausal 
decrease in circulating estrogen that occur in women. 
The reduced energy supply causes a progressive de-
crease in the tonic response of the bladder and urethra. 
In addition to the effects on SM function, atrophy of the 
bladder and urethral mucosal lining increase the inci-
dences of both infection and incontinence (due to the 
loss of the urethral “seal”).
Supporting this argument are the studies by Lin et al.58 
who demonstrated that in aging rats, there was a pro-
gressive decrease in the contractile responses to repeti-
tive autonomic stimulation (increase in fatigue), which 
was directly associated with both a decrease in the meta-
bolic energy available to support the contractile responses 
and a decrease in mitochondrial enzyme activities. Thus, 
in association with aging, there is a progressive reduction 
in the rate of high-energy phosphate generation (during 
periods of stimulation) that significantly increases the 
rate of fatigue of the bladder SM.
Additional support comes from our studies that dem-
onstrated a significant reduction in the ability of isolated 
whole bladders from aged rabbits to generate pressure 
and empty efficiently.59 The rate of power generation, the 
percent emptying, and the amount of work performed 
by bladders from old rabbits were significantly less than 
bladders from young rabbits. In addition, there was a 
marked reduction in the ability of the bladders isolated 
from old rabbits to respond to an increase in outlet re-
sistance. Our studies support the theory that aging is as-
sociated with a progressive reduction in the ability of 
the bladder and urethra to sustain the increased tension 
required for both efficient bladder emptying and conti-
nence. Thus, these studies demonstrate that aging in 
rabbits produce similar LUTD to those seen in women.
We believe that ovariectomy will increase the pro-
gression of age-related LUTD. The observed reduction in 
blood flow to the bladder muscle and mucosa,60,61 the 
increased incidence of hypoxia,60,61 and the increased 
level of free radical oxidation of proteins62–67 all mimic 
what happens in association with aging. In addition, ova-
riectomy also results in a significant decrease in citrate 
synthase activity which is a biomarker enzyme for mito-
chondrial function.68,69 Decreased mitochondrial function 
would mean decreased adenosine triphosphate produc-
tion, which correlates very well with the decreased con-
tractile responses observed following ovariectomy.
Oxidative stress and LUTD in women
Vol. 21, 8–18, March 2010 11
The specific cellular mechanisms involved with the 
aging process in the female bladder are as follows: (1) 
blood flow to the bladder and urethral muscle and 
mucosa are under estrogenic control (see preliminary 
studies),60,61 and blood flow decreased as circulating es-
trogen decreased; (2) decreased blood flow to the blad-
der and urethral SM and mucosa result in localized tissue 
hypoxia and reactive oxygen species (ROS) and reactive 
nitrogen species (RNS) free radical generation;60–62 and 
(3) tissue hypoxia and free radical generation result in 
neuronal and mitochondrial damage as well as increased 
connective tissue formation and SM and mucosal atro-
phy and dysfunction.42–44 The end result of this sequence 
is mucosal atrophy and damage resulting in increased 
incidence of incontinence because of poor urethral mu-
cosal seal and reduced urethral tone and contractile 
force, increased incidences of bladder infection because 
of damaged glycosaminoglycan/mucosal surface layer, 
and bladder and urethral SM weakness that can result in 
decreased voiding pressure and flow (via bladder SM 
weakness).
2. Experimental Results
2.1.  Effect of hypoxia on rabbit urethral 
function
Using an isolated rabbit whole-bladder urethra model,70,71 
we measured the functional ability of the internal sphinc-
ter to open and initiate flow through the intact urethra 
(Figures 1 and 2). We determined the opening pressure 
(which is defined as the intravesical pressure required to 
begin flow) and the flow at opening pressure; resistance 
to flow was calculated from the pressure and flow. The 
basal opening pressure was similar in male and female 
rabbits; however, the flow at opening pressure was four-
fold higher in the females than in the males. Phenylephrine 
increased the opening pressure to a significantly higher 
level in males than in females. Although phenylephrine 
significantly increased opening pressure in both males 
and females, there was no effect of phenylephrine on 
flow at the opening pressure (Figures 1 and 2). Hypoxia 
(5-minute anoxia) reduced opening pressure in both the 
sexes to minimal values and also prevented phenyle-
phrine from stimulating an increase in opening pressure 
(Figures 1 and 2).
These studies demonstrate that under maximal stim-
ulation, the internal sphincter of the female opens at a 
significantly lower intravesical pressure than the male, 
has a significantly higher rate of flow, and has a signifi-
cantly lower resistance to flow. Also, both anoxia and α-
adrenergic blockade with phentolamine reduce opening 
pressure to minimal values. These observations are con-
sistent with the clinical observations that incontinence is 
more prevalent and more severe in females than in males, 
and that α-adrenergic blockade can increase the incidence 
of incontinence by direct relaxation of the urethra. Based 
on these studies, we conclude that the rabbit model of 
urethral function is an appropriate model to study the 
physiologic factors that relate to female urethral function.
2.2.  Effect of aging on rabbit bladder and urethral 
function
New Zealand white rabbits have a life span of approxi-
mately 4 years. We compared bladders isolated from 
mature male rabbits (6 months old) with bladders iso-
lated from 3-year-old male rabbits with respect to their 
functional ability to generate pressure and empty.59 Our 
isolated whole-bladder model allowed us to determine 
pressure, volume emptied, rate of volume emptying, 
power, and work performed by the bladder. In response 
to potassium chloride stimulation, we demonstrated that 
all measured parameters were significantly lower for the 
aged bladders than for the young (Figure 3). In addition, 
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we increased the resistance of the tube the bladder emp-
tied through (high outlet resistance) which further dem-
onstrated that, whereas maximal pressure was affected 
equally for young and old bladders, the volume emptied, 
the power the bladder generated, and the work performed 
all decreased to a further extent in the aged bladders than 
in the young bladders. Very similar results were obtained 
for bethanechol stimulation.
These studies demonstrate that aging primarily affects 
the ability of the bladder to sustain tension in response 
to stimulation, thus reducing the rate at which the bladder 
empties and the volume emptied. In addition, adding a 
stressor (increased outlet resistance) reduced the func-
tional parameters of the aged bladders to a significantly 
greater extent than that of the young bladders, while 
showing a marked increased rate of fatigue with age.
In regard to urethral function, our initial studies indi-
cate that like the bladder, in the aged urethra, there is a 
reduced ability of the urethra to sustain increased ten-
sion in response to phenylephrine and a decreased re-
sponse to repetitive stimulation (increased rate of fatigue). 
These results are consistent with our hypothesis that the 
higher incidence of incontinence in the elderly is due at 
least in part to a reduced ability to sustain α-adrenergic 
tension and an increased rate of fatigue. Although this 
mechanism would affect females to a greater extent 
than males (since women have a greater dependence on 
α-adrenergic tone than men), it would also be an etio-
logic factor for incontinence in the elderly male. These 
results are consistent with the clinical data showing that 
although the incidence of incontinence in both men and 
women increases with age, there is still a significantly 
higher incidence of incontinence in elderly women than 
in elderly men.
2.3.  Comparison of mitochondrial and 
sarcoplasmic reticulum function in male and 
female urethras
We have compared citrate synthase (mitochondrial mar-
ker) and calcium adenosine triphosphatase (sarcoplasmic 
reticulum marker) activities in the proximal, prostatic and 
distal sections of the male urethra and proximal and dis-
tal sections of the female urethra (Table 1).72 These stud-
ies demonstrated clearly that the specific activity of both 
marker enzymes were significantly lower in the proximal 
urethra of the female rabbit than in either the proximal 
or prostatic sections of the male urethra. These results 
correlate very well with the reduced contractile response 
of the female urethra and the decreased resistance to 
flow. It also suggests that the female urethra would be 
more sensitive than the male urethra to changes in oxy-
genation and substrate delivery. Both would be relevant 
to the increased incidence of incontinence in women.
2.4.  Effect of ovariectomy on blood flow, mucosal 
atrophy, mucosal permeability and hypoxia, 
and detrusor contractile function
In males, castration-induced prostate atrophy is initiated 
by apoptosis of the prostate vascular endothelium, result-
ing in endothelial atrophy, vascular degeneration, de-
creased blood flow, and tissue hypoxia. It is the decreased 
blood flow and hypoxia that are proposed to mediate 
prostate atrophy following castration.73,74 We hypothe-
sized that in the female, ovariectomy proceeds in a similar 
sequence resulting, first, in decreased mucosal and detru-
sor blood flow mediated by decreased vascularity followed 
by hypoxia, resulting in detrusor contractile dysfunction, 
mucosal atrophy, detrusor SM regression, and increased 
collagen synthesis.60,61,74,75
In this study, 16 virgin adult female rabbits were divided 
into two equal groups. Ovariectomy was performed on 
Group 1 and sham surgery was performed on Group 2. 
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Table 1  Citrate synthase (CS) and calcium adenosine triphosphatase (CA) of the male (M) and female (F) rabbit urethra*
 M proximal F proximal M prostatic M distal F distal M mucosa F mucosa
CS (nmol/min/mg protein) 100 ± 12 35 ± 3† 150 ± 20 30 ± 2 35 ± 4 45 ± 5 40 ± 3
CA (μmol/min/mg protein) 0.7 ± 0.1 0.4 ± 0.1† 1.2 ± 0.2 1.0 ± 0.1 0.5 ± 0.1† 1.4 ± 0.1 0.6 ± 0.1†
*Data are presented as mean ± standard error of the mean; †significantly different from male at p < 0.05.
Oxidative stress and LUTD in women
Vol. 21, 8–18, March 2010 13
The following analyses were performed 6 weeks after 
ovariectomy.
Blood samples obtained on the day of surgery and 
on the day of the experiment were centrifuged to sepa-
rate the sera which were then sent to Ani Lytics Inc. 
(Gaithersburg, MD, USA) for analysis via the estrogen assay. 
Ovariectomy caused an 80% decrease in serum estrogen.
Bladders from four sham-operated controls and four 
ovariectomized rabbits were evaluated for blood flow at 
6 weeks following surgery. Samples of bladder SM and 
mucosa were evaluated for blood flow using fluorescent 
microspheres and compared with blood flow in the uterus 
and kidney.
Figure 4 shows that ovariectomy caused significant de-
creases in blood flow to the bladder mucosa, SM, and to 
the uterus. No change in kidney blood flow was observed. 
The magnitude of the decreased blood flow to the blad-
der mucosa was significantly greater than the decreased 
blood flow to the detrusor SM.
In these rabbits, Hypoxyprobe-1 (HPI, Inc. Burlington, 
MA, USA) was given intraperitoneally 2 hours before they 
were sacrificed. Transverse sections of bladder were 
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Figure 5 Representative view of hypoxia induced by ovariectomy using Hypoxyprobe-1 immunohistochemistry.
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Figure 6 Representative view of mucosal permeability using 
trypan blue.
evaluated for the presence of Hypoxyprobe-1 protein-
adducts via standard immunohistochemistry.
Figure 5 shows representative sections of sham con-
trol and 6-week ovariectomized rabbits immunostained 
for Hypoxyprobe. There was absolutely no staining in the 
control rabbits. The ovariectomized rabbits showed sig-
nificant and uniform staining of the mucosa and submu-
cosa and dense staining of the vascular endothelium. 
There was some focal staining of the interstitium and SM 
components. Figure 6 shows mucosal permeability to 
trypan blue following hypoxia. Control mucosa was im-
permeable to trypan blue, thus showing the normal pink 
color. After 10 minutes of hypoxia, the bladder mucosa 
became freely permeable to trypan blue, showing the 
marked effect hypoxia has on mucosal permeability.
2.4.1. Histology
Histologic evaluation of control and ovariectomized blad-
ders shows clearly that ovariectomy results in mucosal and 
SM atrophy, and a significant increase in collagen depo-
sition in the detrusor accompanied by SM atrophy.60,61
Figure 7 demonstrates that ovariectomy caused sig-
nificant decreases in both the maximal contractile re-
sponses of the bladder body to field stimulation and the 
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maximal rate of tension generation. Similar decreased 
responses were observed for the effects of ovariectomy 
on the contractile responses to carbachol and potassium 
chloride.
2.5.  Effect of ovariectomy on lipids, 
phospholipids, and prostaglandins
We believe that the key to fully understanding the dys-
functional response of the bladder to ovariectomy lies in 
our understanding of the relationships between lipids, 
phospholipids and prostaglandins, and related bioactive 
compounds.75,76
Figure 8 demonstrates that ovariectomy mediates a 
significant and substantial decrease in both lipid and phos-
pholipid content of the mucosa of the bladder and ure-
thra, and a lower magnitude, yet statistically significant, 
decrease in lipid and phospholipid content of the SM 
compartment.
In a separate study, ovariectomy induced a significant 
and substantial decrease in prostaglandin E in the urinary 
bladder mucosa (Figure 9). The reduction in prostaglandin 
E levels in the mucosa occurred concurrently with low es-
trogen, and suggests that prostaglandin E may be involved 
in the maintenance of mucosal integrity (which is lost dur-
ing periods of low estrogen). Interestingly, prostaglandin E 
of the SM (substantially lower than the concentration in 
the mucosa) increased following ovariectomy. Prostag-
landin F1α showed significant increases in both the SM 
and mucosa.
These current studies clearly demonstrate that ova-
riectomy has marked effects on lipid, phospholipid and 
prostaglandin metabolism.
2.6.  Chronic effects of ovariectomy
One of our current studies asked if the alterations in blad-
der function induced by ovariectomy were maintained, 
or if the bladder recovered from the initial effects of low 
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(p < 0.05); †significantly different from control (p < 0.05).
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Figure 9 Effect of ovariectomy (Ovx) on prostaglandin E (PGE) 
and 6-keto prostaglandin F1α (PGF1α) content of the bladder 
smooth muscle and mucosa. Each bar is the mean ± standard 
error of the mean of 4–6 individual bladders. *Significantly dif-
ferent from smooth muscle (p < 0.05); †significantly different 
from control (p < 0.05).
estrogen. In order to investigate this question, we evalu-
ated the effects of ovariectomy (Ovx) at 3, 7, 14 and 
28 days following surgery.69,77
The results (Figure 10) clearly demonstrate that blad-
der weight and contractile function significantly decreased 
by 3 days and remained consistently low for 28 days after 
surgery.
2.7.  Effects of ovariectomy on free radical 
generation and antioxidant activities
A total of 12 mature female rabbits were divided into three 
groups of four rabbits each: control, ovariectomy, and 
ovariectomy with estradiol supplementation. The bladder 
body (muscle and mucosa) of the rabbits was evaluated 
2 weeks after surgery for superoxide dismut ase (SOD) 
and catalase activities. SOD activities for the mucosa and 
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Figure 10 Chronic effect of ovariectomy (Ovx) on bladder 
weight and the contractile response to carbachol. Each bar is 
the mean ± standard error of the mean of 4–6 individual blad-
ders. *Significantly different from control (p < 0.05).
muscle of the bladder increased after ovariectomy when 
compared with controls. Estradiol replacement caused a 
decrease in SOD activity to control levels. Ovariectomy 
caused a decrease in the catalase activities in the blad-
der tissues, whereas estradiol treatment showed signifi-
cant increases. SOD generates hydrogen peroxide from 
ROS, which is then neutralized by catalase. An increase 
in SOD activity and decreased catalase activity would re-
sult in increased hydrogen peroxide levels, which could be 
more damaging to tissues than the ROS themselves.62,67
In a separate experiment, 12 female rabbits were 
divided into three groups of four rabbits each: sham 
controls, 1-day ovariectomy, and 3-day ovariectomy. The 
bladder body (muscle and mucosa) of the rabbits was 
evaluated for the concentration of carbonyl groups (2,4-
dinitrophenylhydrazine [DNP]) as a marker for ROS ac-
tivity and nitrotyrosine as a marker for RNS activity. 
Figure 11 shows that at 3 days following ovariectomy, both 
DNP and nitrotyrosine were significantly increased over 
sham surgery levels (Figure 11), with DNP rising to a higher 
level than nitrotyrosine. This study confirms that there 
was increased oxidative damage to both muscle and mu-
cosa, simultaneous with the observed decrease in blood 
flow and increased levels of hypoxia of the tissues.
2.8. Effects of cyclical estrogen
Interstitial cystitis is a debilitating disease that primarily 
affects women. We believe that interstitial cystitis is di-
rectly related to cyclical alterations in bladder mucosal 
blood flow, structure, and permeability properties medi-
ated by the cyclic nature of circulating estrogen that oc-
curs during the menstrual cycle. Our hypothesis is as 
follows: the menstrual cycle is characterized by cyclical 
changes in circulating hormones including estrogen. Blood 
flow to the bladder mucosa is modulated by changes in 
circulating estrogen. Specifically, bladder mucosal blood 
flow is decreased during low estrogen periods, resulting 
in mucosal hypoxia, apoptosis, thinning (atrophy), and 
increased permeability. Blood flow increases during high 
Figure 11 Effect of ovariectomy (Ovx) the oxidative products 
nitrotyrosine and 2,4-dinitrophenylhydrazine (DNP) of the blad-
der smooth muscle and mucosa. Each bar is the mean ± stand-
ard error of the mean of 4–6 individual bladders. *Significantly 
different from control (sham) (p < 0.05).
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estrogen periods, which causes mucosal hyperplasia, 
thickening of the mucosa, decreased permeability, and 
increased generation of free radicals (ROS and RNS).
Interstitial cystitis is mediated in sensitive women by 
both the mucosal hypoxia/ischemia that occurs during 
periods of reduced blood flow and free radical damage 
that occurs during the period of increasing blood flow. 
Specifically, it is progressive damage to the sensory affer-
ent nerves localized in the mucosal–submucosal area that 
mediate the symptoms of interstitial cystitis (pain upon 
distension, urgency, and frequency).
In order to investigate this hypothesis, we performed 
the following experiment: Forty adult female New Zealand 
white rabbits were divided into five groups of eight rab-
bits each. Group 1 served as the control group. Groups 2 
through 5 received bilateral ovariectomy. Group 2 (Ovx) 
received no estradiol. Four rabbits were studied 4 weeks 
after ovariectomy and four at 8 weeks following surgery. 
Group 3 (Ovx + E) received 17-β estradiol by subcutane-
ous slow-release tablet. Four rabbits were studied 4 
weeks after ovariectomy and four at 8 weeks following 
surgery. Group 4 received estradiol immediately follow-
ing surgery, while Group 5 received estradiol beginning 
2 weeks following surgery. Groups 4 and 5 had the estra-
diol tablets removed after 2 weeks of estradiol administra-
tion and re-implanted 2 weeks after being off estrogen. 
In this way, Groups 4 and 5 were cycled on and off of estro-
gen every 2 weeks. Four rabbits in Group 4 were studied 
after two complete cycles and four after four complete 
cycles. Group 4 (Cyclic − E) were studied after the last 
2 weeks off of estrogen. The rabbits in Group 5 (Cyclic + E) 
were studied at the end of a 2-week on estrogen cycle. 
There were no significant differences between the 2- and 
4-week cycle rabbits.74,78
Figure 12 presents the mean bladder weight and vol-
ume fraction of SM for each of the five study groups. 
Ovariectomy had no significant effect on bladder weight, 
whereas estrogen administration showed a significant 
increase in bladder weight. Removal of the estrogen tab-
let caused no significant change in bladder weight from 
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the estrogen group. Re-adding estrogen stimulated an 
additional significant increase in bladder weight. In regard 
to the volume fraction of SM within the bladder, the blad-
ders of Groups 3 and 5 rabbits clearly show SM hyper-
trophy, which is reflected in the significant increase in 
the volume fraction of SM in these groups compared 
with control, Ovx, and Cyclic − E (Figure 12). Thus, these 
results demonstrate that cyclical estrogen has significant 
effects on bladder structure.
Figure 13 presents the vascular density and blood flow 
of the bladder. There were clear increases in vascular 
density and blood flow in both the Ovx + E and Cyclic + E 
groups when compared to the control, Ovx, and Cyclic – E 
groups. Table 2 gives the relative concentrations of ni-
trotyrosine and DNP of the five groups (normalized to 
control, 100). The concentrations of both oxidative prod-
ucts were high in the Ovx and Cyclic–E groups compared 
with the Ovx + E and Cyclic + E groups.
3. Conclusion
The urinary bladder goes through similar cycles of growth 
and atrophy as does the uterus but just not to the same 
degree. These structural and functional changes are sec-
ondary to the cyclical changes in blood flow and vascular 
density. The end result is that we believe that bladder 
function in female rabbits will decrease faster with aging 
following ovariectomy than in control rabbits, and that it 
will be slowest in rabbits given supplemental estrogen.
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